This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Jan. 2, 2018

Providing Guardrails

Kevin Marks’ work giving legal guidance to an expanding Roche Molecular is personal.

Read more about Kevin Marks...
Roche Molecular Systems Inc.

As the general counsel for Roche Molecular Solutions Inc., Kevin A. Marks takes his work home with him. His grandmother’s cancer treatments included a drug from the pharmacology division of Roche Holding AG, his employer’s parent company. His mother’s macular degeneration is being treated with products manufactured by Genentech Inc., a Roche subsidiary since 2009.

“There is a direct correlation between products that are ... (continued)

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Already a subscriber?

Sign up for Daily Journal emails